TerminatedEUCTR 2005-005499-34
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GreeceSchizophreniaHistorical research record
- Countries
- Greece
- Sponsor
- H. Lundbeck A/S
TerminatedEUCTR 2010-018911-13
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophrenia, BipolarityHistorical research record
- Countries
- Bulgaria, Hungary, Poland
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedEUCTR 2009-017853-36
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanySchizophreniaHistorical research record
- Countries
- Germany
- Sponsor
- Eli Lilly and Company
CompletedEUCTR 2008-007307-91
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanySchizophreniaHistorical research record
- Countries
- Germany
- Sponsor
- Eli Lilly and Company
CompletedEUCTR 2011-002514-37
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In LatviaSchizophreniaHistorical research record
- Countries
- Latvia, Poland, Slovakia
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedEUCTR 2007-000800-34
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaSchizophreniaHistorical research record
- Countries
- Austria, Germany, Portugal
- Sponsor
- Eli Lilly and Company Ltd.
CompletedEUCTR 2010-018408-96
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophreniaHistorical research record
- Countries
- Bulgaria
- Sponsor
- Schering-Plough Research Institute, a Division of Schering
CompletedEUCTR 2009-017852-28
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanySchizophreniaHistorical research record
- Countries
- Germany
- Sponsor
- Eli Lilly and Company
CompletedEUCTR 2009-012568-14
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophreniaHistorical research record
- Countries
- Bulgaria, Slovakia
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
TerminatedEUCTR 2011-004845-42
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicSchizophreniaHistorical research record
- Countries
- United Kingdom, Czechia, Poland
- Sponsor
- Amgen Inc.
CompletedEUCTR 2011-004844-23
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalySchizophreniaHistorical research record
- Countries
- Italy, Spain
- Sponsor
- Amgen Inc.
CompletedEUCTR 2016-003436-20
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophreniaHistorical research record
- Countries
- Bulgaria, Czechia, Hungary, + 2 others
- Sponsor
- ACADIA Pharmaceuticals Inc.